• Guideline Summary
  • NGC:009332
  • 2007 Jun (revised 2012 Sep)

Alteplase for treating acute ischaemic stroke (review of technology appraisal guidance 122).

  • Guideline Summary
  • NGC:009801
  • 2013 Apr

Pirfenidone for treating idiopathic pulmonary fibrosis.

  • Guideline Summary
  • NGC:009154
  • 2012 May 10

Best evidence statement (BESt). Sleep promotion in children with mental health diagnoses.

  • Guideline Summary
  • NGC:010348
  • 2014 Apr

Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer.

  • Guideline Summary
  • NGC:009739
  • 2013 Feb

Guidelines for the minimally invasive treatment of adrenal pathology.

  • Guideline Summary
  • NGC:009574
  • 2003 Sep (revised 2013 Feb)

Benefits and risks of sterilization.

  • Guideline Summary
  • NGC:010817
  • 2015 Oct 7

Pembrolizumab for treating advanced melanoma after disease progression with ipilimumab.

  • Guideline Summary
  • NGC:010003
  • 2006 Apr 3 (revised 2013 Mar 18)

Bortezomib in multiple myeloma and lymphoma.

  • Guideline Summary
  • NGC:010497
  • 2014 Jul

Ipilimumab for previously untreated advanced (unresectable or metastatic) melanoma.

  • Guideline Summary
  • NGC:010622
  • 2014 Dec

Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism.

  • Guideline Summary
  • NGC:010791
  • 2015 Aug

Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism.

  • Guideline Summary
  • NGC:010070
  • 2013 Oct

Ocriplasmin for treating vitreomacular traction.

  • Guideline Summary
  • NGC:010418
  • 2013 Oct

Recommendations for drug therapies for relapsing-remitting multiple sclerosis.

  • Guideline Summary
  • NGC:010999
  • 2016 May 25

Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes.